TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $321,000 | -31.4% | 717,800 | +4.4% | 0.93% | +155.8% |
| Q2 2019 | $468,000 | -42.3% | 687,653 | +16.1% | 0.36% | -12.1% |
| Q1 2019 | $811,000 | +33.2% | 592,232 | -38.8% | 0.41% | +6.2% |
| Q4 2018 | $609,000 | -22.1% | 966,975 | +153.5% | 0.39% | +9.3% |
| Q3 2018 | $782,000 | -35.8% | 381,409 | -15.5% | 0.36% | -23.5% |
| Q2 2018 | $1,219,000 | – | 451,607 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |